View Post

HHV-6 small non-coding RNA proposed as an indicator of an early stage of HHV-6 reactivation

In All, Alzheimer's Disease, Latest Scientific News by Kristin Loomis

German investigators have identified a marker for what they believe is the earliest stage of viral reactivation, or “transactivation” marked by transcription of several viral small non-coding RNAs in the absence of detectable viral replication. The group believes that these viral small RNAs could be developed as biomarkers.

View Post

Gene-expression network analysis points to HHV-6A as a key driver in upregulating genes leading to Alzheimer’s disease progression

In All, Alzheimer's Disease, CNS Disease, CNS Dysfunction by Kristin Loomis

Investigators at Mt Sinai used “big data” models to determine that the genes involved with fighting Alzheimer’s are the same ones that fight virus. They found HHV-6A and HHV-7 to be more abundant in Alzheimer’s brains, and singled out HHV6-A as a key modulator of the genes involved in amyloidosis and neuronal death.